69
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Prevalence and factors of polypharmacy among disease-free survivors of adults after allogeneic hematopoietic cell transplantation

, , , , , , , , , & ORCID Icon show all
Pages 516-520 | Received 08 Nov 2023, Accepted 19 Dec 2023, Published online: 27 Dec 2023

References

  • Khera N, Storer B, Flowers ME, et al. Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation. J Clin Oncol. 2012;30(1):71–77. doi:10.1200/JCO.2011.38.4594
  • Masnoon N, Shakib S, Kalisch-Ellett L, et al. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. doi:10.1186/s12877-017-0621-2
  • Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65. doi:10.1517/14740338.2013.827660
  • Murphy CC, Fullington HM, Alvarez CA, et al. Polypharmacy and patterns of prescription medication use among cancer survivors. Cancer. 2018;124(13):2850–2857. doi:10.1002/cncr.31389
  • Betts AC, Murphy CC, Shay LA, et al. Polypharmacy and prescription medication use in a population-based sample of adolescent and young adult cancer survivors. J Cancer Surviv. 2023;17(4):1149–1160. doi:10.1007/s11764-021-01161-0
  • Elliot K, Tooze JA, Geller R, et al. The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML). Leuk Res. 2014;38(10):1184–1190. doi:10.1016/j.leukres.2014.06.018
  • Dhakal P, Lyden E, Muir KE, et al. Prevalence and effects of polypharmacy on overall survival in acute myeloid leukemia. Leuk Lymphoma. 2020;61(7):1702–1708. doi:10.1080/10428194.2020.1737687
  • Sugidono M, Lo M, Young R, et al. Impact of polypharmacy prior to allogeneic hematopoietic stem cell transplantation in older adults. Transplant Cell Ther. 2021;27(4):344.e1-344–e5. doi:10.1016/j.jtct.2021.01.001
  • Ewig CLY, Cheng YM, Li HS, et al. Use of chronic prescription medications and prevalence of polypharmacy in survivors of childhood cancer. Front Oncol. 2021;11:642544. doi:10.3389/fonc.2021.642544
  • Babcock ZR, Kogut SJ, Vyas A. Association between polypharmacy and health-related quality of life among cancer survivors in the United States. J Cancer Surviv. 2020;14(1):89–99. doi:10.1007/s11764-019-00837-y
  • Lee SJ, Kim HT, Ho VT, et al. Quality of life associated with acute and chronic graft-versus-host disease. Bone Marrow Transplant. 2006;38(4):305–310. doi:10.1038/sj.bmt.1705434
  • Newell LF, Flowers ME, Gooley TA, et al. Characteristics of chronic GVHD after cord blood transplantation. Bone Marrow Transplant. 2013;48(10):1285–1290. doi:10.1038/bmt.2013.48
  • Baker KS, Ness KK, Steinberger J, et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood. 2007;109(4):1765–1772. doi:10.1182/blood-2006-05-022335
  • Delara M, Murray L, Jafari B, et al. Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatr. 2022;22(1):601. Erratum in: BMC Geriatr. 2022 Sep 12;22(1):742. doi:10.1186/s12877-022-03279-x
  • Holmes HM, Des Bordes JK, Kebriaei P, et al. Optimal screening for geriatric assessment in older allogeneic hematopoietic cell transplantation candidates. J Geriatr Oncol. 2014;5(4):422–430. doi:10.1016/j.jgo.2014.04.004

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.